[Target next generation sequencing-based gene panels in tumors of unknown origin]
Gonzalez L, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Bardach A, Ciapponi A
Record ID 32018001574
Spanish
Original Title:
Paneles genéticos (Target NGS) en tumores de origen desconocido
Authors' recommendations:
Moderate-quality evidence suggests that in patients with metastatic cancer of unknown origin, determining the probable primary site through molecular profiling and later treatment selection would not result in a significant improvement in overall survival, progression-free survival or response rate when compared with the use of empirical chemotherapy.
There is consensus among the clinical practice guidelines from the main international societies and different funders consulted on not covering its use as standard of care for this group of patients.
No cost-effectiveness or budget impact studies have been found in Latin America.
Details
Project Status:
Completed
Year Published:
2020
URL for published report:
https://www.iecs.org.ar/home-ets/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Argentina
MeSH Terms
- Neoplasms
- Genetic Testing
- DNA Mutational Analysis
- Biomarkers, Tumor
Contact
Organisation Name:
Institute for Clinical Effectiveness and Health Policy
Contact Address:
Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name:
info@iecs.org.ar
Contact Email:
info@iecs.org.ar
Copyright:
Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.